Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies
Clinical trial NCT04994093 · COMPLETED
Trial details
- NCT number
- NCT04994093
- Sponsor
- Ardigen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-06
- Primary completion
- 2022-12-05
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.